1. Ali, B. H., Agents ameliorating or augmenting experimental gentamicin nephrotoxicity: some recent research. Food Chem. Toxicol., 41, 1447–1452 (2003).
2. Benko, A. S., Cappelletty, D. M., Kruse, J. A., and Rybak, M. J., Continuous infusion versus intermittent administration of ceftazidime in critically ill patients with suspected gram-negative infections. Antimicrob. Agents Chemother., 40, 691–695 (1996).
3. Botzenhart, K. and Kufferath, R., On the growth of various Enterobacteriaceae, Pseudomonas aeruginosa and Alkaligenes spec. in distilled water, de-ionized water, tap water and mineral salt solution. Zentralbl. Bakteriol. Orig. B, 163, 470–485 (1976).
4. Bukholm, G., Tannaes, T., Kjelsberg, A. B., and Smith-Erichsen, N., An outbreak of multidrug-resistant Pseudomonas aeruginosa associated with increased risk of patient death in an intensive care unit. Infect. Control Hosp. Epidemiol., 23, 441–446 (2002).
5. Bukowska, D., Wegrzynowicz, Z., Rudowski, W., Kraj, M., Rosiek, A., Gardzińska, E., and Popiel, D., Use of human anti-pseudomonas immunoglobulins treatment in children with burns. Pol. Tyg. Lek., 51, 331–333 (1996).